Cleveland Clinic researchers reveal biomarker for guiding prostate cancer treatment
October 12, 2017, Cleveland: Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-related genetic abnormality can help predict individual patient responses...





